Europa

Diabetes report 2000 — 2045

Estimates were made for 59 countries and territories in the IDF Europe (EUR) Region. A total of 60 data sources from 39 countries were used to generate diabetes estimates among adults in the Region. Estimates for 14 countries (Austria, Denmark, Finland, France, Georgia, Greece, , Greenland, Hungary, Lithuania, Malta, Russian Federation, Turkmenistan, United Kingdom, and Uzbekistan) were based on studies conducted within the past five years.

IDF projects that diabetes prevalence (9.2%) and number of people with diabetes (61 million) in EUR Region will increase 13 % by 2045. EUR Region has the highest number of children and adolescents with type 1 diabetes (295,000) as well as the highest incidence annually with 31,000 new cases per year. The EUR Region has also the second highest average cost per person with diabetes (USD 3,086). In 2021, 189.3 billion USD was spent on diabetes, representing 19.6% of the total spent worldwide.

Key Messages

An approximate 59 million adults aged 20–79 years are living with diabetes in the IDF Europe Region. This represents close to 9% of the regional population in this age group.

41% (24 million) of adults aged 20–79 years with diabetes are undiagnosed.

Nearly 37 million adults aged 20–79 years are estimated to have impaired glucose tolerance. This represents almost 6% of the regional population in this age group.

The IDF Europe Region has the highest number of children and adolescents (0–19 years) with type 1 diabetes – 297,000 in total.

31% of diabetes-related deaths are in people under the age of 60 years.

At a glance	2000	2011	2021	2030	2045
Diabetes estimates (20-79 y)
People with diabetes, in 1,000s	22,373.1	52,770.8	61,425.1	67,000.0	69,000.0
Age-adjusted comparative prevalence of diabetes, %	4.9	6.7	7.0	8.0	8.7
People with undiagnosed diabetes, in 1,000s	-	-	21,935.0	-	-
Proportion of people with undiagnosed diabetes, %	-	-	35.7	-	-